Fuan Pharmaceutical (Group) Co (SZSE:300194) ROCE % : 12.57% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fuan Pharmaceutical (Group) Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.57%.

Fuan Pharmaceutical (Group) Co ROCE % Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co ROCE % Chart

Fuan Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.36

5.56

-12.25

4.80

6.83

Fuan Pharmaceutical (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															8.97	7.16	8.24	1.77	12.57

Fuan Pharmaceutical (Group) Co ROCE % Calculation

Fuan Pharmaceutical (Group) Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	319.923	/	( ( (5877.98 - 1287.061)	+	(5975.931 - 1195.046) )	/ 2 )
	=	319.923	/	( (4590.919	+	4780.885)	/ 2 )
	=	319.923	/	4685.902
	=	6.83 %

Fuan Pharmaceutical (Group) Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	602.248	/	( ( (5975.931 - 1195.046)	+	(6018.781 - 1215.022) )	/ 2 )
	=	602.248	/	( ( 4780.885	+	4803.759 )	/ 2 )
	=	602.248	/	4792.322
	=	12.57 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Fuan Pharmaceutical (Group) Co (SZSE:300194) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fuan Pharmaceutical (Group) Co ROCE % Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254

Website

http://www.fapharm.com

Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines